GALVOSURGE
LIVE

Serial Number

79151856

Owner

Zyfoma GmbH

Attorney

Lina A. Asmar

Filing Date

Mar 5, 2014

Add to watchlist:

No watchlists yet
View on USPTO

GALVOSURGE Trademark

Serial Number: 79151856 • Registration: 4805930

GALVOSURGE is a trademark filed by Zyfoma GmbH on March 5, 2014. The trademark is classified under Class 3 (Cosmetics & Cleaning), Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus). The application is currently registered and active.

Owner Contact Info

Zyfoma GmbH (5 trademarks)

Waldstraße 19a

Entity Type: 27

Holger Zipprich

Bleichweg 7a

Entity Type: 01

Dr. Markus Schlee

Breitenlohestr. 31a

Entity Type: 01

Trademark Details

Filing Date

March 5, 2014

Registration Date

September 8, 2015

Published for Opposition

June 23, 2015

Cancellation Date

March 20, 2026

Goods & Services

Alcohol for pharmaceutical purposes; Analgesic and muscle relaxant pharmaceutical preparations; Antibacterial pharmaceuticals; Antimicrobial preparations for inhibiting microbiological decomposition in food, beverages, animal feed and pharmaceuticals; Anti-diabetic pharmaceuticals; Balms for pharmaceutical purposes; Bicarbonate of soda for pharmaceutical purposes; Bismuth preparations for pharmaceutical purposes; Bismuth subnitrate for pharmaceutical purposes; Bromine for pharmaceutical purposes; Ferments for pharmaceutical purposes; Flour for pharmaceutical purposes; Frostbite salve for pharmaceutical purposes, Hyaluronic acid for pharmaceutical purposes, Hydrated chioral for pharmaceutical purposes; Iodine for pharmaceutical purposes; Menthol for pharmaceutical purposes; Pharmaceutical antitussive-cold preparations; Pharmaceutical preparations for wounds; Pharmaceutical and veterinary preparations, namely, anticoagulants, antidepressants, a blood clotting aid and delivery system for use in human and veterinary medicine; Analgesic for human consumption taken orally; Pharmaceutical preparations for the prevention and treatment of ocular disorders or diseases, for the treatment of bacteria-based diseases, and for the treatment of diabetes, and anti-infective preparations, antiviral preparations, antibiotics, antifungal preparations and vaccines; Pharmaceutical preparations for the prevention and treatment of ocular disorders or diseases, bacteria-based diseases or disorders, autoimmune diseases or disorders, kidney diseases or disorders, and diabetes; Pharmaceutical products for the treatment of joint disease; Pharmaceutical products for treating respiratory diseases; Sanitary preparations for medical purposes, namely, chemical preparations, disinfectants, napkins, pads, panties, tampons towels; Sanitary preparations for medical use; Food for babies; Dietary supplements for human beings and animals; Medical plasters; dressings for wounds, burns, bandages, gauze, medical and surgical purposes; Teeth filling material and dental impression materials; Disinfectants for sanitary purposes; Preparations for destroying noxious animals; Fungicides; Herbicides

Surgical apparatus and instruments for medical, dental or veterinary use; prosthetic limbs, namely, arms, feet; artificial eyes and teeth; orthopedic articles, namely, apparatus and instruments for diagnostic and therapeutic use, belts, braces, cushions and padding, devices for diagnostic and therapeutic use, joint implants made of artificial materials, support bandages, plaster casts; suture materials

Polishes for dentures, bridges and surgical implants; preparations for cleaning dentures, bridges and surgical implants; dental bleaching gels; dentifrices

Filing History

CANCELLED SECTION 71
Mar 20, 2026 C71T
COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED
Sep 8, 2024 REM4
INTERNATIONAL REGISTRATION RENEWED
May 2, 2024 RNWL
NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
Jun 30, 2022 NA71
REGISTERED-SEC.71 ACCEPTED
Jun 30, 2022 71AG
TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
Jun 7, 2022 EROP
POST REGISTRATION ACTION MAILED - SEC.71
Jan 5, 2022 PR71
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Nov 8, 2021 APRE
TEAS SECTION 71 RECEIVED
Jun 1, 2021 ES71
NEW REPRESENTATIVE AT IB RECEIVED
Mar 22, 2019 NREP
CHANGE OF OWNER RECEIVED FROM IB
Aug 18, 2016 CHLD
FINAL DECISION TRANSACTION PROCESSED BY IB
Feb 27, 2016 FINO
GENERIC MADRID TRANSACTION SENT TO IB
Jan 20, 2016 XXSS
GENERIC MADRID TRANSACTION CREATED
Jan 20, 2016 XXCR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Dec 8, 2015 FICR
REGISTERED-PRINCIPAL REGISTER
Sep 8, 2015 R.PR
PUBLISHED FOR OPPOSITION
Jun 23, 2015 PUBO
NOTICE OF PUBLICATION
Jun 3, 2015 NPUB
LAW OFFICE PUBLICATION REVIEW COMPLETED
May 18, 2015 PREV
APPROVED FOR PUB - PRINCIPAL REGISTER
May 15, 2015 CNSA
EXAMINERS AMENDMENT MAILED
May 12, 2015 CNEA
EXAMINER'S AMENDMENT ENTERED
May 12, 2015 XAEC
EXAMINERS AMENDMENT -WRITTEN
May 12, 2015 CNEA
PREVIOUS ALLOWANCE COUNT WITHDRAWN
May 5, 2015 ZZZX
WITHDRAWN FROM PUB - OG REVIEW QUERY
Apr 28, 2015 PBCR
LAW OFFICE PUBLICATION REVIEW COMPLETED
Apr 11, 2015 PREV
APPROVED FOR PUB - PRINCIPAL REGISTER
Apr 10, 2015 CNSA
AMENDMENT FROM APPLICANT ENTERED
Mar 26, 2015 ACEC
CORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 26, 2015 CRFA
ASSIGNED TO LIE
Mar 20, 2015 ALIE
PAPER RECEIVED
Mar 18, 2015 MAIL
PAPER RECEIVED
Mar 12, 2015 MAIL
FAX RECEIVED
Mar 12, 2015 FAXX
REFUSAL PROCESSED BY IB
Oct 10, 2014 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Sep 25, 2014 RFCS
REFUSAL PROCESSED BY MPU
Sep 25, 2014 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Sep 25, 2014 RFCR
NON-FINAL ACTION WRITTEN
Sep 24, 2014 CNRT
APPLICATION FILING RECEIPT MAILED
Sep 23, 2014 MAFR
ASSIGNED TO EXAMINER
Sep 17, 2014 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Sep 17, 2014 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Sep 11, 2014 REPR